TGFBR2 and neoplasm: Our previous study shows that there is a high level of chromatin deacetylation in the promoter of TβRII gene and histone deacetylase inhibitors can in part restore TβRII expression and TGF-β-induced tumor suppressor functions in lung cancer cells [11].